MATCHES Intervention to Promote Colorectal Cancer and Hepatitis C Screening Among Adults Aged 45 to 75 at Federally Qualified Health Centers
Led by H. Lee Moffitt Cancer Center and Research Institute · Updated on 2026-09-16
350
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying a combined education and screening approach called the Multilevel Action Toward Colorectal Cancer CRC and Hepatitis C Virus HCV Education and Screening MATCHES intervention to promote screening for both HCV and CRC among patients aged 45 to 75 who receive care at participating federally qualified health centers FQHCs. This study focuses on patient-level strategies within a multi-level intervention to encourage timely screening for these conditions.
The MATCHES intervention includes three main patient-level strategies an educational booklet with information about CRC and HCV in English or Spanish, access to free stool-based CRC screening, and access to free HCV antibody testing. Participants will receive these education materials either in person or by mail. Approximately 1 to 2 weeks after receiving the materials, participants will complete a follow-up survey by phone to assess knowledge, beliefs, screening intentions, and healthcare experiences. Those with positive screening results will be guided to follow-up care as needed.
Participants will be involved in completing surveys before and after receiving the intervention materials, either by phone or remote interviews for some. Researchers will measure screening uptake for HCV and CRC over 12 months and track screening completions and test results for up to 41 months. The study monitors the completion of repeat CRC screening and evaluates the impact of the education and screening intervention. The total study duration extends until April 2028.
CONDITIONS
Brief Title
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
Research Team
C
Carol Boxtha
S
Shannon Christy, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
H. Lee Moffitt Cancer Center and Research Institute
Lead Sponsor
Florida Biomedical Research Program - Bankhead Coley
Collaborating Sponsor
How This Trial Compares With Other Options
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
MATCHES Multilevel Education and Screening
Standard Education, Screening Access, and Navigation
What it is
A multilevel behavioral intervention providing education (booklet), survey assessment, and access to free stool-based colorectal cancer and hepatitis C screening, plus navigation to follow-up care if screening is positive.
Standard practice involves general education, routine offer of CRC and HCV screening, and access to navigation for follow-up, but without multilevel MATCHES materials, structured survey assessment, or targeted navigation process as studied.
Role in the study
Used as the only assigned arm for eligible adults not up to date with CRC or HCV screening, evaluated for screening uptake.
Serves as the usual screening, education, and navigation pathway offered to similarly eligible adults at FQHC clinics, representing current care outside of study participation.
Primary use
To improve uptake of colorectal cancer and hepatitis C screening, knowledge, attitudes, and navigation to follow-up for adults not previously screened.
To encourage completion of guideline-recommended CRC and HCV screening and connect eligible adults to standard screening and follow-up care.
How it is given or performed
Participants receive education materials (booklet), complete a survey before and after, are offered free CRC stool test and HCV blood test, followed by navigation to care if positive.
Adults typically receive brief verbal or written education, are offered CRC and HCV screening, and are referred for follow-up, but processes are less structured and may lack targeted materials or navigation support as in MATCHES.
Evidence status
Ongoing study; no published results for screening uptake, attitudes, or follow-up yet.
Multiple published studies and guidelines document CRC and HCV screening uptake in routine primary care, generally suboptimal, and endorse further improvement interventions.
Important limitations
Single-group design; results depend on implementation and participant engagement; generalizability to other settings is unknown; screening and navigation may be influenced by additional social factors.
Standard education and screening approaches at FQHCs may reach fewer eligible adults, lack multilevel support, and have limited engagement/navigation; uptake remains below desired levels despite guideline endorsement.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 45Years - 75Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Participants must be receiving care at one of the participating federally qualified health centers.
Participants must be between 45 and 75 years of age.
Participants must not be up to date with colorectal cancer screening recommendations, such as no colonoscopy in the past 10 years or occult blood test in the past 12 months.
Participants must never have had Hepatitis C Virus antibody screening.
Participants must be able to read, write, and understand English or Spanish.
Participants must have no personal history of colorectal cancer or current symptoms like unresolved rectal bleeding or abdominal pain/bloating.
Participants must be at average risk for colorectal cancer, meaning no hereditary syndromes or strong family history.
Participants must be asymptomatic for Hepatitis C Virus.
Participants receiving intervention materials must be able and willing to complete surveys and receive the patient-level intervention.
Participants completing qualitative interviews must be willing to complete remote interviews by phone or teleconference.
Participants completing qualitative interviews must be willing to be audio recorded.
Participants recruited for qualitative interviews only must have had a clinic visit within the prior two months.
All participants must be able to provide informed consent.
You will not qualify if you...
Participants who do not meet all inclusion eligibility requirements will be excluded.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Intervention
Duration - Up to 41 months
Participants receive educational materials about colorectal cancer and Hepatitis C, access free stool-based colorectal cancer screening, and free Hepatitis C antibody testing. They complete surveys before and after receiving materials, and may participate in remote interviews.
Surveys and screening follow-up as scheduled
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Similar Trials
Development and Validation of a Noninvasive Blood Test Using MicroRNA to Detect Multiple Gastrointestinal Cancers Early
Evaluating a Short Animated Storytelling Video to Increase Intent for Colorectal Cancer Screening in U.S. Adults An Online Randomized Trial
Comparing Low-Volume Tablet and Standard Liquid Bowel Preparations for Colonoscopy
A Study of Patient Preferences and Tolerance in Outpatient Settings
Understanding and Improving Colorectal Cancer Screening for Adults Aged 45 to 54 at a Community Health Center
Early Information and General Practitioner Endorsement to Improve Colonoscopy Follow-up After Positive Colorectal Cancer Screening A Randomized Controlled Trial SUIVICOLO
Study Comparing Different Ratios of Electrolyte Beverage and Water Mixed with Polyethylene Glycol for Bowel Preparation Quality Before Colonoscopy
Training General Practitioners in Patient-centered Care to Improve Shared Decision-making for Colorectal Cancer Screening in Adults Aged 50 to 74
Study to Find Gut Microbiome Markers in Stool for Early Detection and Screening of Colorectal Cancer in Adults Aged 40 to 74 in Lisbon, Portugal
Diet and Lifestyle Advice to Prevent Colorectal Cancer
in Adults Aged 35 to 74 at Higher Risk in France
MATCHES Intervention to Promote Colorectal Cancer and Hepatitis C Screening Among Adults Aged 45 to 75 at Federally Qualified Health Centers
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening (MATCHES): Study protocol for a hybrid 1 stepped-wedge multibehavioral randomized trial.